Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

[Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].

Debarre JM.

Ann Dermatol Venereol. 2013 Jun-Jul;140(6-7):474-8. doi: 10.1016/j.annder.2013.04.093. Epub 2013 May 31. French. No abstract available.

PMID:
23773753
2.

[Oral contraceptives, risks and hazards].

Revuz J.

Ann Dermatol Venereol. 2014 Jan;141(1):5-6. doi: 10.1016/j.annder.2013.12.001. Epub 2014 Jan 10. French. No abstract available.

PMID:
24461087
3.

Too much disclosure of product risks? CBC television, SOGC, and Diane-35.

Mintzes B, Lexchin J, Lippman A, Ford AR.

J Obstet Gynaecol Can. 2003 Apr;25(4):268-9; discussion 270-3. No abstract available.

PMID:
12679817
4.

European Commission orders France to lift ban on acne pill.

Arie S.

BMJ. 2013 Aug 5;347:f4932. doi: 10.1136/bmj.f4932. No abstract available.

PMID:
23918671
5.

Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.

Franks S, Layton A, Glasier A.

Hum Reprod. 2008 Feb;23(2):231-2. Epub 2007 Dec 14.

PMID:
18083746
6.

Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.

Kromm J, Jeerakathil T.

CMAJ. 2014 Jun 10;186(9):690-3. doi: 10.1503/cmaj.130579. Epub 2014 Feb 3. No abstract available.

7.

Diane-35 (cyproterone acetate): safety concerns.

Wooltorton E.

CMAJ. 2003 Feb 18;168(4):455-6. No abstract available.

9.

Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.

Heuser P, Tonga K, Hopkins R, Henderson M, Weatherall M, Metcalfe S, Beasley R.

N Z Med J. 2004 Nov 26;117(1206):U1176.

PMID:
15570345
10.
11.

First-use risks.

Rowe TC.

CMAJ. 2003 May 27;168(11):1394. No abstract available.

12.

Venous thrombosis with cyproterone (continued).

[No authors listed]

Prescrire Int. 2004 Apr;13(70):59. No abstract available.

PMID:
15148982
14.

[The hypocrisy of Diane®].

Revuz J.

Ann Dermatol Venereol. 2013 Apr;140(4):249-50. doi: 10.1016/j.annder.2013.02.004. Epub 2013 Mar 7. French. No abstract available.

PMID:
23567222
15.

[A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].

Vignini M, Pelfini C, Montanari L.

Minerva Ginecol. 1988 Feb;40(2):125-32. Italian. No abstract available.

PMID:
2969466
16.

[Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].

Levrier M, Degrelle H, Bestaux Y, Bourry-Moreno M, Brun JP, Sailly F.

Rev Fr Gynecol Obstet. 1988 Jul-Sep;83(7-9):573-6. French.

PMID:
2973646
17.

[Cyproterone acetate].

Borelli C.

Hautarzt. 2002 Feb;53(2):149. German. No abstract available.

PMID:
11963195
18.
19.

Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.

Vaidya RA, Shringi MS, Vaidya AB, Gogate JG.

J Assoc Physicians India. 1997 Nov;45(11):883-4. No abstract available.

PMID:
11229194
20.

Cyclic cyproterone/ethinyloestradiol for acne.

[No authors listed]

Lancet. 1983 Aug 20;2(8347):458. No abstract available.

PMID:
6135942

Supplemental Content

Support Center